Abstract
Non-enveloped Nackednaviridae and enveloped hepadnaviridae both have capsids that are formed by related small proteins which evolved more than 430 Mya. In Hepatitis B virus, which belongs to the enveloped hepadnaviridae, this small protein is termed Hepatitis B core protein (Hbc). Its function, as building block of a major human pathogen, triggered extensive research that elucidated the importance of almost every single amino acid for the structural integrity of the capsids and the orderly progression of the viral life cycle. In particular, encapsidation of the genome, envelopment of the capsid, uncoating of the genome and targeting of the different compartments during viral maturation have been a vivid focus of research. HBc has also been developed as a biotechnological tool for the design of nano-containers with tailored properties. These nano-containers can display foreign epitopes on their surfaces and induce a strong immune response, which is attractive for the development of vaccines against other pathogens. This chapter will discuss some of the unique properties of HBc and their significance for the formation of a functional macromolecular capsid.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Hepatitis B virus
- Hepatitis B core protein
- Icosahedral capsid
- Spike
- Nano-container
- C-terminal domain
- Assembly domain
- Arginine-rich domain
Hepatitis B Core Protein a Component of the Hepatitis B Virus
Hepatitis B Virus (HBV) belongs to the family of Hepadnaviridae and is a major human pathogen. Approximately one third of the world population has been in contact with the virus (Alter 2003) and around 250 million have become chronic carriers with an increased risk for developing liver cirrhosis and primary liver cancer. The virions consist of two shells. The outer shell is a membrane containing envelope, which is densely packed with surface proteins (HBs). The inner shell is a capsid that is formed entirely by a protein called hepatitis B core protein (HBc) or Hepatitis B core antigen (HBcAg). These HBc subunits assemble around a complex of viral pregenomic (pg) RNA and viral polymerase (protein P) (for review see Nassal 2008; Ning et al. 2017) and form an icosahedral capsid. Inside the capsid the viral polymerase reversely transcribes the RNA into partly double-stranded (ds) DNA. After reverse transcription is completed, capsids are either targeted towards the nucleus (early after infection) or they are enveloped by a lipid membrane, which is densely packed with HBs (Fig. 14.1). These mature virions (Summers and Mason 1982) are secreted together with a huge excess of subviral particles formed by HBs and virus-like, enveloped particles containing empty, highly phosphorylated HBc capsids (Ning et al. 2011).
The viral envelope is densely packed with three types of surface proteins (HBs) which are termed large (L), medium (M) and small (S). All types have of HBs have the same C-terminal membrane-embedded domain that comprises S-HBs and consists of 4 transmembrane helices. M-HBs and L-HBs have N-terminal additions of increasing length. These additions are termed preS2 for the part that is common in M-HBs and L-HBs and preS1, for the part which is unique to L-HBs. The whole N-terminal extension to S-HBs in L-HBs is commonly referred to as the PreS-domain (Fig. 14.1). For the envelopment of HBc L-HBs and S-HBs are important while M-HBs is dispensable. It is still an ongoing debate where the binding site for these two surface proteins on the capsids is.
In the envelope, L-HBs has a dual function as it binds to the cellular receptor during infection and to the capsid during envelopment. This is achieved by a dual topology (Bruss et al. 1994) in which the N-terminus of L-HBs can either face the luminal or cytosolic site of the membrane (Fig. 14.1, topo I and topo II). Viral secretion by budding requires enveloped particles. Infective particles include capsids with a mature DNA-genome and an envelope that contains L-HBs. All other types of secreted particles are none infective.
Structure of Hepatitis B Core Protein
The capsid forming human HBc is a small protein of only 183–185 amino acid residues. It consists of an N-terminal assembly domain (1–144), which forms the ordered part of the capsid and a C-terminal domain (CTD), which is largely disordered. The CTD is rich in arginines (arginine rich domain, ARD) and contains several phosphorylation sites, a nuclear export signal (NES) and nuclear localization signals (NLS) (Fig. 14.2). Thus the CTD accommodates the main functional sites of HBc that control ordered progression of viral maturation and its localization within the host cell.
The structure of the assembly domain of HBc is known from numerous studies by electron cryomicroscopy (Crowther et al. 1994; Kenney et al. 1995; Bottcher et al. 1997; Yu et al. 2013; Böttcher and Nassal 2018; Conway et al. 1997; Schlicksup et al. 2018) and X-ray crystallography (Alexander et al. 2013; Bourne et al. 2006; Venkatakrishnan et al. 2016; Wynne et al. 1999). The assembly domain is mainly α-helical and contains 5 helices (Bottcher et al. 1997; Wynne et al. 1999), which are numbered from the N- to the C-terminus (I–V). The N-terminal part of the assembly domain (residues 1–48) accommodates two short helices connected by extended strands of protein. This N-terminal part resembles a fulcrum and loops around the central helical hairpin formed by the two longest helices III and IV (residues 48–111). The central helical hairpin is followed by helix V which together with a subsequent proline rich turn and an extended stretch form a hand-like region (Fig. 14.2). Helices IV and V are flexibly linked at Gly 111 (Böttcher et al. 2006; Packianathan et al. 2010), enabling a hinge-like movement between the two domains.
Most structures resolve the assembly domain only up to residue 144 and in some exceptional cases up to residue 152 (Böttcher and Nassal 2018). However, the density downstream of residue 144 is very weak suggesting either flexibility or lower occupancy with some of the C-termini being in different conformations. This region between the ordered well-resolved assembly domain and the unresolved ARD is often referred to as linker-region. The unresolved residues following 152 contain the Arginine rich domain and the phosphorylation sites of which seven can be phosphorylated in one HBc-monomer in vitro (Heger-Stevic et al. 2018a).
HBc Forms Dimeric Building Blocks
The Hbc monomer on its own is most likely unstable and has not been observed in solution yet. Folding experiments suggest that two HBc monomers associate as partly unfolded proteins into a dimer and then fold together (Alexander et al. 2013) into a mature dimer. The dimers are hammerhead-shaped (Crowther et al. 1994) with the handle as the inner dimer interface. This interface is formed by helices III and IV of each monomer. The dimer is further stabilized by an inner-dimer SS-bridge (Fig. 14.3, magenta) between Cys 61 (Fig. 14.2, yellow) in the center of helix III. The SS-bridge is dispensable for dimer and capsid formation (Nassal 1992) and slows down capsid assembly in vitro (Selzer et al. 2014).
HBc, C-terminally truncated at residue 138, cannot assemble into capsids and remains in its dimeric form, while longer constructs are able to assemble into capsids under favourable conditions (Zlotnick et al. 1996). The dimeric form is also stabilized over capsids at pH 9.5 and at low ionic strength (Wingfield et al. 1995) and stays dimeric under reducing conditions, even at high protein concentrations (Freund et al. 2008). Certain point mutations abrogate the ability of HBc to assemble into capsids but still support the dimer formation. The probably best-known point mutation that abolishes capsid formation is an exchange of Tyrosine132 to Alanine. This position is at the strained turn of the hand region (Fig. 14.3). In human HBc such mutants form stable, planar trimers of dimers whereas in woodchuck HBc the corresponding mutant forms dimers (Zhao et al. 2019). The inability of these mutants to form capsids and their ability to form well diffracting crystals, made them an important construct for routine high-resolution studies of effector binding (Zhou et al. 2017; Qiu et al. 2016; Klumpp et al. 2015) well below 2 Å resolution. Other point mutations in the fulcrum such as F23A and L42A (Fig. 14.3) also abolish capsid formation and lead to dimers that are stable under a wide range of conditions (Alexander et al. 2013).
Hbc Dimers Assemble into Icosahedral Capsids
Dimers are the main building block from which capsids with either T = 3 (180 subunits) or T = 4 (240 subunits) triangulation are formed. The diameter of the capsids across the tips of the spikes is 36 nm for T = 4 capsids and 32 nm for T = 3 capsids (Crowther et al. 1994). Thus T = 3 capsids provide about 70% of the volume of T = 4 capsids. The asymmetric units of T = 4 and T = 3 capsids both contain two types of HBc dimers with different spatial surroundings (Fig. 14.4): One type of dimer is located between a fivefold and a local sixfold symmetry axis (blue, cyan in Fig. 14.4) and the other is placed between two local sixfold symmetry axes (red, yellow in Fig. 14.4). In T = 4 capsids the dimer axes of all dimers are located at local twofold symmetry axes, meaning that these dimers do not have perfect twofold symmetry and the individual monomers deviate slightly in their structures to adapt to the different spatial surroundings. In T = 3 capsids only one of the two dimers is located at a local twofold symmetry axes whereas the other dimer is located at a strict two-fold axis and contributes only one of its monomers to the asymmetric unit. The dimer at the strict two-fold symmetry axis in the T = 3 particles has perfect two-fold symmetry with both monomers having identical structures.
Within the capsids the hammerhead-shaped dimers are orientated such that the head is part of the continuous protein shell and the handle forms a protruding spike. Thus capsids have either 90 (T = 3 particle) or 120 (T = 4 particle) spikes at their surface. At either side of the spikes are large triangular holes of approximately 2 nm diameter that fenestrate the capsid shell and are large enough to be crossed by small molecules or nucleotides.
In the capsids the hand-like C-terminal regions of the assembly domains, which form the opposite tips of the hammerhead, mediate the inter-dimer contacts. Either five or six of these hand-like regions assemble around strict five-fold-symmetry axes and the local six-fold symmetry axes respectively. These different spatial environments require slight adaptations in the structure of the protein (Fig. 14.4) that manifests as a swivel of the hand region relative to the spike with Gly111 as a hinge. Solid State NMR confirms that the hand region comprises a dynamic region between residues 121 and 135 and a bending region between residues 117 and 120 that differ in their chemical shifts between the 4 monomers in the asymmetric unit (Lecoq et al. 2018).
T = 4 capsids are more common than T = 3 capsids and account for more than 90% of capsids in virions (Roseman et al. 2005; Seitz et al. 2007; Dryden et al. 2006). Early experiments with HBc expressed in E. coli suggested that the CTD and especially the linker region between assembly domain and ARD (Watts et al. 2002) is decisive for whether T = 3 or T = 4 capsids are formed. In addition full length HBc had a strong dimorphism (Wingfield et al. 1995; Crowther et al. 1994) whereas HBc truncated at position 149 formed mainly T = 4 particles (Zlotnick et al. 1996). Later experiments with optimized, heterologous expression systems did not confirm the earlier described dimorphism of full length wt-HBc (e.g. Böttcher and Nassal 2018.) suggesting that higher dimer concentrations are another decisive factor that controls the speed of capsid assembly (Lutomski et al. 2017) as well as the ratio between T = 3 and T = 4 particles. (Harms et al. 2015). The critical dimer-concentration of truncated HBc1–149 for capsid formation is around 0.5 µM and is the same for T = 3 and T = 4 particles (Harms et al. 2015).
Important Sites of the Assembly Domain
HBc is densely packed with functionally important sites. Some of them map to the ordered assembly domain while others are located in the disordered CTD, which probably changes its accessibility during viral maturation. The assembly domain harbours sites that are important for capsid assembly, immunogenicity, formation of virions and secretion (Fig. 14.5). Many functionally important sites map to the inner dimer interface such as the tips of the spikes and the surroundings of a hydrophobic pocket inside the spikes; others are located at the inter-dimer interface like a hydrophobic Heteroaryldihydropyrimidine pocket between the hand region and fulcrum (Venkatakrishnan et al. 2016).
In addition individual, exposed residues of the hand region (R127, I126, F122, A137, N136, and I139) at the outer surface of the spike (L60, L95, and K96) and at the fulcrum (S17, F18) (Fig. 14.5) are essential for the secretion of enveloped virions with a mature genome (Ponsel and Bruss 2003). Even conservative mutations of these key residues abrogate secretion of virions with mature genome (Ponsel and Bruss 2003) but not that of empty, enveloped capsids (Ning et al. 2018).
The Tips of the Spikes
The tips of the spikes are the most exposed site of the capsids and form the major immuno-dominant loop (Fig. 14.5) and probably the binding platform for the envelope. The tips of the spikes consists of the tight loops between helix III and IV containing residues 77–81. Each monomer contributes one of these loops to the tips. This generates a characteristic cleft between the two loops, which could act as potential binding site for other factors. The widths and length of the cleft is only large enough to support direct contact to 2–3 amino acids. The tip of the spikes contains 4 negatively charged residues which accumulate in the cleft providing an exposed platform for potential electrostatic interactions (Fig. 14.6). Furthermore, the tips together with the upper half of the spikes are more flexible than the rest of the capsid as indicated by the high B-factors and the low local resolution in this region of the capsids (Böttcher and Nassal 2018). MD simulations (Hadden et al. 2018) suggest that the tips sample a wide conformational space forming a dynamic cleft between the loops. These observations agree with a potential binding site for small binders following an induced fit mechanism.
The tips of the spikes also harbour the main immunogenic loop, which is centred on residue 80 (Salfeld et al. 1989; Conway et al. 1998; Belnap et al. 2003) at the start of helix IV. Deletion of residue 80 (Fig. 14.5, magenta) abolishes the reaction with human anti-HBc positive serum (Koschel et al. 2000) confirming the location of the immunogenic loop close to the tips of the spikes. Some antibodies show a strong preference for certain quasi-equivalent sites over others (Wu et al. 2013; Conway et al. 2003; Harris et al. 2006) demonstrating that the conformational differences between the four monomers in the asymmetric unit of the capsid can be recognized by antibodies although the structural differences of the four monomers are very minor at this position (Fig. 14.5). In certain complications of Hepatitis B virus infection that lead to acute liver failure, a strong B-cell response causes massive production of IgG against HBc (Farci et al. 2010). Antibodies from such patients bind towards the side of the spikes peripheral to the major immune dominant loop and show a strong conformational preference for some of the monomers over others (Wu et al. 2013). Typically only one monomer per dimer has a bound antibody and within the spatial context of the asymmetric unit it is always the same.
The tips of the spikes are also the contact sites with the envelope in virions (Dryden et al. 2006; Seitz et al. 2007) and bind to fragments of PreS and S-HBs (Muhamad et al. 2015). NMR-studies suggest that the S-HBs fragment forms a short helical segment and the PreS fragment a tight loop, which both bind with one face to the cleft at the tips of the spikes (Muhamad et al. 2015). Peptides that interfere with binding of L-HBs to the capsids (Dyson and Murray 1995) also attach to the tips of the spikes at the cleft at the tips of the spikes (Böttcher et al. 1998; Freund et al. 2008). Contacts between capsid and envelope appear variable from varying directions (Seitz et al. 2007). Although these observations strongly suggest that the tips of the spikes are the binding sites between capsid and envelope, none of the residues at the tips of the spikes appears to be of importance for envelopment, virion formation or secretion according to extensive mutational screens (Koschel et al. 2000; Ponsel and Bruss 2003). This apparent contradiction is not yet fully resolved and might hint to an unspecific electrostatic interaction between HBc and the envelope and could reflect the different roles of S-HBs and L-HBs in envelopment with PreS probably mediating the specific contact away from the tips of the spikes (Ponsel and Bruss 2003; Pastor et al. 2019).
The Hydrophobic Pocket Inside the Spikes
The spikes accommodate a hydrophobic pocket (Fig. 14.6, lower panel, arrow) in the centre of the spikes, which harbours Cys61 and F/I97. In capsids derived from patients’ serum (Roseman et al. 2005) and in some samples of capsids derived from HBc over-expressed in E. coli (Böttcher and Nassal 2018) the pocket contains an unknown factor. Its small size is consistent with a small molecule or an individual amino-acid side chain rather than with a folded motif of a potential protein binding partner. The pocket is of interest because it is lined by numerous residues that have been implicated in either low or premature secretion phenotypes. In particular residue 97 is implicated in premature secretion. In wt-Hbc this position is typically occupied by a large hydrophobic residue, such as phenylalanine (e.g. strains ayw and adyw) or isoleucine (e.g. strains adr and adw); however, in some naturally occurring mutants, these bulky residues are replaced by a smaller leucine. These mutants have a premature secretion phenotype such that capsids containing ssDNA are enveloped (Yuan et al. 1999a, b).
Structural differences between capsids of wt-HBc and of F97L-mutant are subtle and impact the side chain orientation of residues 97 in helix IV and the disulphide-bridge at the adjacent helix III, which is always reduced in 97L but not in 97F. Both changes together enlarge the hydrophobic pocket (Böttcher and Nassal 2018) such that the pocket factor can penetrate deeper into the spike. The entrance of the pocket is also lined by P5 and L60 (Fig. 14.5, orange) which if mutated to P5T or to L60V are implicated with low level secretion phenotypes and are naturally occurring variants of the Hepatitis B Virus (Le Pogam et al. 2000). Residue 5 is close to the N-terminus of HBc, which is largely disordered in freshly prepared, phosphorylated capsids and folds slowly over a couple of days (Heger-Stevic et al. 2018b). This slow maturation in vitro might hint at a cis–trans isomerization of the proline which is generally catalysed by peptidyl-prolyl-cis-trans-isomerases in vivo. Mutations of the proline are likely to abolish the structural maturation and thus interfere with processes that sense a folded N-terminal region. In vivo experiments in Huh cells show that mutating any of the pocket delineating residues L60, L95, K96 and I126 to smaller alanines abrogates binding of the L-HBs to HBc (Pastor et al. 2019). All these observations suggest that the pocket could be involved in binding PreS but is generally too small to accommodate parts of the PreS-sequence directly.
The Hydrophobic Pocket at the Inter Dimer Interface
HBc-dimers interact around the five-fold and local six-fold symmetry axes by packing the hand region of one dimer against the fulcrum and the hand region of the adjacent dimer. This inter-dimer contact forms a hydrophobic pocket between two dimers to which assembly modulators bind (Venkatakrishnan et al. 2016; Schlicksup et al. 2018). These assembly modulators fall into two categories: The heteroaryldihydropyrimidine-derivates (HAP) (Stray et al. 2005) and the phenylpropenamide-derivates (Katen et al. 2010). While HAP-derivates lead to aberrant structures (Stray et al. 2005) phenylpropenamides accelerate capsid assembly and maintain the capsid structure (Katen et al. 2010). Both types of modulators have antiviral potential (for review see Zlotnick et al. 2015) but have a different mode of action. HAPs probably act by accumulating hexamers of dimers as intermediates (Stray et al. 2005). These hexamers are well stabilized and can lead to tube-like assemblies with hexamers of dimers as main building block (Liu et al. 2017). In contrast phenylpropenamides lead to accelerated formation of intact capsids that then progress into empty enveloped virus-like particles (Feld et al. 2007). HAP and Phenylpropenamides both intercalate between helix V of the hand region in one dimer and helix IV of the spike below the fulcrum of the other dimer (Schlicksup et al. 2018; Katen et al. 2013). The changes in the individual asymmetric units are small but lead to large range distortions that accumulate in the capsid structures (Katen et al. 2013).
Most of the structural binding studies of these modulators have used C-terminally truncated HBc1-149-variants. The truncation removes the ARD of the CTD and abolishes unspecific interactions with RNA. The resulting capsids are more homogeneous and therefore are better amenable to high-resolution structure determination. However, in capsids C-terminally truncated HBc and full length HBc have a somewhat different orientation of the C-terminal tail of the assembly domain (Yu et al. 2013), which impacts the inter-dimeric hydrophobic pocket. Superposing structures of truncated HBc variants with bound modulator (Schlicksup et al. 2018; Venkatakrishnan et al. 2016; Katen et al. 2013) with full length HBc-capsids suggests that the modulators also affect residues 151–152 of the adjacent subunit (Böttcher and Nassal 2018) making an even more extended contact at the interdimer interface than suggested by the studies of the truncated HBc1–149. It is likely that part of the mode of action of the assembly modulators is in co-ordinating the CTD and accelerating the interaction of these only weakly ordered residues to form stable capsids. Recently, more substance classes were discovered (Huber et al. 2019; Corcuera et al. 2018) which also target the same hydrophobic pocket and modulate capsid assembly. These modulators provide a versatile toolbox for interfering with viral maturation and thus for the development of new antiviral strategies.
The C-Terminal Domain (CTD)
The CTD downstream of residue 144 is largely disordered. It can be divided into a linker region and the arginine rich domain (ARD). Parts of the linker region have been resolved as weak density in high resolution EM-maps of empty, phosphorylated capsids (Böttcher and Nassal 2018). This linker region folds into a kinked stretch that resembles the loop and stretch of the hand region. The linker packs against the last resolved residues of the assembly domain in the adjacent dimer and contributes to the inter-dimer contact. This involvement in inter-dimer contacts probably explains its impact on the morphology of capsids (Zlotnick et al. 1996).
The ARD downstream of the linker has many positive charges located at 16 arginines and interacts randomly with host-RNA. These arginines are interspersed with six serines, which can be phosphorylated and which are phosphorylated in HBc-dimers prior to capsid assembly (Zhao et al. 2018). There is evidence that the dephosphorylation of HBc is concomitant with the encapsidation of the pregenomic RNA (Zhao et al. 2018). If HBc is phosphorylated in vitro, capsids no longer incorporate random host RNA and remain empty (Heger-Stevic et al. 2018b). Similarly, the packaging of host RNA is reduced by phosphorylation mimics in which three of the serines are replaced by negatively charged glutamates (Porterfield et al. 2010). Thus, stable incorporation of the genome probably requires a fine-tuned charge balance between negative charges contributed by the genome and the phosphorylated serines and the positive charges contributed by the arginines (Le Pogam et al. 2005). Phosphorylation of the CTD has no impact on the structure of the assembly domain (Böttcher and Nassal 2018; Heger-Stevic et al. 2018b). Therefore, a conformational change of the capsid cannot act as a maturation signal that directs the capsid either towards envelopment or to the nucleus. However, differences in the accessibility of the CTD in phosphorylated and unphosphorylated capsids as well as capsids of phosphorylation mimics are evident by a changed accessibility to proteases (Heger-Stevic et al. 2018b; Selzer et al. 2015). Such conformational accessibility-switch is an attractive mode for guiding maturation as it either masks or unmasks the nuclear localization signal. However, it is difficult to understand what the actual driver of this maturation is. Some experiments compare the accessibility of the CTD to trypsin digestion in empty capsids that have been generated from HBc dimers in the absence of RNA (Selzer et al. 2015), whereas other experiments compare capsids that self-assemble in E. coli (Heger-Stevic et al. 2018b) and balance their charge by either picking up RNA (unphosphorylated) or remaining empty (phosphorylated). Accordingly, the observations differ and show different degrees of protection of the CTD. Unfortunately, protease protection assays cannot distinguish whether accessibility has changed due to a partial disintegration of the capsids or a genuine conformational switch. Studies on nucleocapsids with mature genome suggest that the maturation leads to a destabilization of the capsids probably with partial disintegration (Cui et al. 2013), which could explain changes in accessibility to proteases. In contrast, structural studies, and especially those aiming at high-resolution select for the most intact particles and discard information from a large percentage of particles, which are structurally more variable or damaged but could account for the observed changed accessibility.
Assuming a conformational switch that makes the CTD accessible to the outside without damaging the gross architecture of the capsids raises the question where the CTDs emerge from the capsid. Electron microscopic studies of capsids with Import in ß bound to the CTD suggests that the CTD egresses through the holes at the local six-fold axes (Chen et al. 2016). However, these holes are narrow and cannot easily widen to accommodate an extended peptide stretch without a simultaneous rearrangement of the adjacent hand regions. Far more attractive are the large holes at the base of the spikes. With a diameter of some 2 nm, they are large enough to support the exit of one or two extended stretches of the CTD. In agreement with this model are observations on phosphorylated HBc capsids, which show the last resolved residues of the assembly domain extending towards the large holes adjacent to the base of the spikes (Heger-Stevic et al. 2018b; Böttcher and Nassal 2018). Furthermore, in the phosphorylated premature envelopment mutant F97L the three most C-terminal residues of the CTD (181–183) are located at the base of the spikes directly adjacent to the large holes (Böttcher and Nassal 2018). This locates the C-termini of HBc at the capsid interior at a favourable position for exposure through the adjacent large holes without the need of capsid reorganization in the assembly domain.
Evolution of Capsids
Hepadnaviridae and the related Nackednaviridae are found in almost all vertebrates, including fish (Hahn et al. 2015), amphibians (Dill et al. 2016), birds and mammals. Phylogenetic analysis suggests that both families emerged from a common ancestor some 430 Mya (Lauber et al. 2017). While the non-enveloped Nackednaviridae are only reported in fish, the enveloped Hepadnaviridae are found in mammals (Orthohepadnavirusses), birds (Avihepatovirusses), reptiles, amphibian (Herpetohepadnavirusses) and in some fish (Meta- and Parahepdanaviruses) (Lauber et al. 2017; Schaefer 2007). The non-enveloped Nackednaviridae have a capsid that is structurally similar to the human HBc capsids (Lauber et al. 2017) but probably evolved much earlier. Phylogenetic comparison identify three conserved motifs in the capsid proteins (Dill et al. 2016), which include the surface-exposed side of the hand region, parts of the fulcrum and the tight kink between helix IV and IV connecting the spike domain to the hand region (Fig. 14.5, blue). All three motifs are in close proximity to the hydrophobic pocket at the inter dimer interface, suggesting that important sites for capsid formation are conserved over geological ages. In contrast, residues at the inner-dimer interface and at the tips of the spikes are not conserved. While most capsid proteins are relatively small with some 180+ residues the capsid proteins of Avihepadnaviruses in birds and Herpetohepadnaviruses in reptiles and amphibians have much larger capsid proteins of some 260+ residues. The most remarkable difference of these larger variants compared to the other capsid proteins are extensions of some 40–50 residues replacing the tips of the spikes (Nassal et al. 2007). This demonstrates the structural variability of the spike region. Recent unpublished data shows that in duck Hepatitis B capsid protein (DHBc) this extension domain folds separately and much more slowly than the rest of the capsid protein (Makbul et al. 2020), The extension domain packs to the side of the spikes as already suggested by the earlier discovered broad spikes of DHBc capsids (Kenney et al. 1995) and contributes almost 50% of the area of the inner-dimer interface. Thus it adds an important contribution to capsid stability (Makbul et al. 2020). The inner dimer contact within the core spike of DHBc is also changed in comparison to HBc with an altered twist of the helices III and IV and a stabilization of the contact by stacking of aromatic residues rather than an inner-dimer di-sulphide bridge (Makbul et al. 2020). These observations further highlight the fact that the inner-dimer interface in the related core proteins is much less conserved than the inter-dimer packing.
HBc Capsids as Tool in Biotechnology
The ability of HBc to self-assemble into capsids has been fascinating for many researchers and was quickly developed into a tool to display other proteins or protein fragments at the surface of capsids (Schodel et al. 1992; Borisova et al. 1996; Ulrich et al. 1998). Large insertions are tolerated at the tips of the spikes without abolishing particle formation. Depending on the size of the inserted protein these particles have some 40–60 nm diameter and carry up to 240 foreign protein fragments at their surface. This spatially condensed display of protruding epitopes is conceptually interesting for the generation of vaccines that trigger a strong immune response. HBc is a particularly attractive carrier, as it is not infectious on its own, triggers a strong B cell, T cell and CTL response (Milich et al. 1995) and is directly displayed in B cells in mice (Milich et al. 1997). Systematic structural screening has shown that the tips of the spikes tolerate the insertion of whole proteins such as GFP (Kratz et al. 1999; Böttcher et al. 2006) or the dimeric outer surface lipoprotein C (OspC) of the Lyme disease (Skamel et al. 2006). However, insertions into HBc at the tips of the spikes requires that the C- and N-terminus of the inserted fragment are in close proximity and that spatial clashes of the two displayed proteins on the same spike do not interfere with the independent folding of HBc and the inserted protein. Some residual conformational stress at the tips of the spikes is generally well tolerated by the capsids but is propagated through the capsid scaffold and leads to distortions of the capsid that are hinged at Gly 111 at the joint between helix IV in the spike and helix V in the hand-region (Böttcher et al. 2006). This type of conformational stress occurs during protein folding and capsid formation. It is also possible to induce conformational stress post capsid formation. For this an acidic insertion domain is introduced which forms a coiled coil helix with a complementary basic peptide (peptide velcro) but is disordered without the binding partner (O'Shea et al. 1993). In the absence of the complimentary peptide, capsids have the expected structure of wt-HBc capsids. The large acidic insertions are not resolved by electron cryo-microscopy, which is expected for an unfolded insert. Upon addition of the complimentary basic peptide, capsids completely disintegrate (Böttcher et al. 2006). This enables a triggered opening of an artificial HBc-based nano-container.
Spatial constraints restrict which proteins and protein fragments can be inserted to the tips of the spikes. These constraints are partly eliminated by using very long flexible linkers, which give the foreign fragment the freedom to fold independently of the icosahedral capsid scaffold. Similarly, using mosaic particles of wt-HBc and chimeric HBc (Vogel et al. 2005) with an inserted foreign protein (fragment) relieve the spatial constraints by reducing the number of surface-exposed foreign epitopes. However, insertions of proteins in which C- and N-terminus are distant remain problematic. Here a different strategy which uses “split cores” was designed (Walker et al. 2011). In these constructs HBc1–149 is split at the tips of the spikes between helices III and IV into an N-terminal and a C-terminal protein. These two split-core proteins still assemble into icosahedral capsids and also do so when foreign proteins are inserted at the tips of the spikes. This strategy by Walker and co-workers allows the expression of the foreign proteins at the C-or N-terminal end of the split-core rather than in a conformationally more constraint loop and has been successfully used for more problematic inserts.
References
Alexander CG, Jurgens MC, Shepherd DA, Freund SM, Ashcroft AE, Ferguson N (2013) Thermodynamic origins of protein folding, allostery, and capsid formation in the human hepatitis B virus core protein. Proc Natl Acad Sci USA 110(30):E2782-2791. https://doi.org/10.1073/pnas.1308846110[pii]
Alter MJ (2003) Epidemiology of hepatitis B in Europe and worldwide. J Hepatol 39(Suppl 1):S64-69
Belnap DM, Watts NR, Conway JF, Cheng N, Stahl SJ, Wingfield PT, Steven AC (2003) Diversity of core antigen epitopes of hepatitis B virus. Proc Natl Acad Sci USA 100(19):10884–10889
Borisova G, Borschukova Wanst O, Mezule G, Skrastina D, Petrovskis I, Dislers A, Pumpens P, Grens E (1996) Spatial structure and insertion capacity of immunodominant region of hepatitis B core antigen. Intervirology 39(1–2):16–22. https://doi.org/10.1159/000150470
Böttcher B, Nassal M (2018) Structure of mutant hepatitis B core protein capsids with premature secretion phenotype. J Mol Biol 430:4941–4954. https://doi.org/10.1016/j.jmb.2018.10.018
Bottcher B, Wynne SA, Crowther RA (1997) Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature 386(6620):88–91. https://doi.org/10.1038/386088a0
Böttcher B, Vogel M, Ploss M, Nassal M (2006) High plasticity of the hepatitis B virus capsid revealed by conformational stress. J Mol Biol 356(3):812–822
Böttcher B, Tsuji N, Takahashi H, Dyson MR, Zhao S, Crowther RA, Murray K (1998) Peptides that block hepatitis B virus assembly: analysis by cryomicroscopy, mutagenesis and transfection. EMBO J 17(23):6839–6845
Bourne CR, Finn MG, Zlotnick A (2006) Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1. J Virol 80(22):11055–11061. JVI.00933-06 [pii] https://doi.org/10.1128/JVI.00933-06
Bruss V, Lu X, Thomssen R, Gerlich WH (1994) Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein. EMBO J 13(10):2273–2279
Chen C, Wang JC, Pierson EE, Keifer DZ, Delaleau M, Gallucci L, Cazenave C, Kann M, Jarrold MF, Zlotnick A (2016) Importin beta can bind hepatitis B virus core protein and empty core-like particles and induce structural changes. PLoS Pathog 12(8):e1005802. https://doi.org/10.1371/journal.ppat.1005802
Conway JF, Chenng N, Zlotnick A, Wingfield PT, Stahl SJ, Steven AC (1997) Visualization of a4-helix bundle in the hepatitis B virus capsid by cryo-electron microscopy. Nature 368(6):91–94
Conway JF, Watts NR, Belnap DM, Cheng N, Stahl SJ, Wingfield PT, Steven AC (2003) Characterization of a conformational epitope on hepatitis B virus core antigen and quasiequivalent variations in antibody binding. J Virol 77(11):6466–6473
Conway JF, Cheng N, Zlotnick A, Stahl SJ, Wingfield PT, Belnap DM, Kanngiesser U, Noah M, Steven AC (1998) Hepatitis B virus capsid: localization of the putative immunodominant loop (residues 78 to 83) on the capsid surface, and implications for the distinction between c and e-antigens. J Mol Biol 279(5):1111–1121
Corcuera A, Stolle K, Hillmer S, Seitz S, Lee JY, Bartenschlager R, Birkmann A, Urban A (2018) Novel non-heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro. Antiviral Res 158:135–142. https://doi.org/10.1016/j.antiviral.2018.07.011
Crowther RA, Kiselev NA, Bottcher B, Berriman JA, Borisova GP, Ose V, Pumpens P (1994) Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 77:943–950
Cui X, Ludgate L, Ning X, Hu J (2013) Maturation-associated destabilization of hepatitis B virus nucleocapsid. J Virol 87(21):11494–11503. https://doi.org/10.1128/JVI.01912-13
Dill JA, Camus AC, Leary JH, Di Giallonardo F, Holmes EC, Ng TF (2016) Distinct viral lineages from fish and amphibians reveal the complex evolutionary history of hepadnaviruses. J Virol 90(17):7920–7933. https://doi.org/10.1128/JVI.00832-16
Dryden KA, Wieland SF, Whitten-Bauer C, Gerin JL, Chisari FV, Yeager M (2006) Native hepatitis B virions and capsids visualized by electron cryomicroscopy. Mol Cell 22(6):843–850
Dyson MR, Murray K (1995) Selection of peptide inhibitors of interactions involved in complex protein assemblies: association of the core and surface antigens of hepatitis B virus. Proc Natl Acad Sci USA 92:2194–2198
Farci P, Diaz G, Chen Z, Govindarajan S, Tice A, Agulto L, Pittaluga S, Boon D, Yu C, Engle RE, Haas M, Simon R, Purcell RH, Zamboni F (2010) B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure. Proc Natl Acad Sci USA 107(19):8766–8771. https://doi.org/10.1073/pnas.1003854107
Feld JJ, Colledge D, Sozzi V, Edwards R, Littlejohn M, Locarnini SA (2007) The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging. Antiviral Res 76(2):168–177. https://doi.org/10.1016/j.antiviral.2007.06.014
Freund SM, Johnson CM, Jaulent AM, Ferguson N (2008) Moving towards high-resolution descriptions of the molecular interactions and structural rearrangements of the human hepatitis B core protein. J Mol Biol 384(5):1301–1313. S0022-2836(08)01292-8 [pii] https://doi.org/10.1016/j.jmb.2008.10.020
Hadden JA, Perilla JR, Schlicksup CJ, Venkatakrishnan B, Zlotnick A, Schulten K (2018) All-atom molecular dynamics of the HBV capsid reveals insights into biological function and cryo-EM resolution limits. eLife 7. https://doi.org/10.7554/eLife.32478
Hahn CM, Iwanowicz LR, Cornman RS, Conway CM, Winton JR, Blazer VS (2015) Characterization of a novel hepadnavirus in the white sucker (Catostomus commersonii) from the Great Lakes Region of the United States. J Virol 89(23):11801–11811. https://doi.org/10.1128/JVI.01278-15
Harms ZD, Selzer L, Zlotnick A, Jacobson SC (2015) Monitoring assembly of virus capsids with nanofluidic devices. ACS Nano 9(9):9087–9096. https://doi.org/10.1021/acsnano.5b03231
Harris A, Belnap DM, Watts NR, Conway JF, Cheng N, Stahl SJ, Vethanayagam JG, Wingfield PT, Steven AC (2006) Epitope diversity of hepatitis B virus capsids: quasi-equivalent variations in spike epitopes and binding of different antibodies to the same epitope. J Mol Biol 355(3):562–576
Heger-Stevic J, Kolb P, Walker A, Nassal M (2018a) Displaying whole-chain proteins on hepatitis B virus capsid-like particles. Methods Mol Biol 1776:503–531. https://doi.org/10.1007/978-1-4939-7808-3_33
Heger-Stevic J, Zimmermann P, Lecoq L, Bottcher B, Nassal M (2018b) Hepatitis B virus core protein phosphorylation: identification of the SRPK1 target sites and impact of their occupancy on RNA binding and capsid structure. PLoS Pathog 14(12):e1007488. https://doi.org/10.1371/journal.ppat.1007488
Huber AD, Pineda DL, Liu D, Boschert KN, Gres AT, Wolf JJ, Coonrod EM, Tang J, Laughlin TG, Yang Q, Puray-Chavez MN, Ji J, Singh K, Kirby KA, Wang Z, Sarafianos SG (2019) Novel hepatitis B virus capsid-targeting antiviral that aggregates core particles and inhibits nuclear entry of viral cores. ACS Infect Dis 5(5):750–758. https://doi.org/10.1021/acsinfecdis.8b00235
Katen SP, Chirapu SR, Finn MG, Zlotnick A (2010) Trapping of hepatitis B virus capsid assembly intermediates by phenylpropenamide assembly accelerators. ACS Chem Biol 5(12):1125–1136. https://doi.org/10.1021/cb100275b
Katen SP, Tan Z, Chirapu SR, Finn MG, Zlotnick A (2013) Assembly-directed antivirals differentially bind quasiequivalent pockets to modify hepatitis B virus capsid tertiary and quaternary structure. Structure 21(8):1406–1416. https://doi.org/10.1016/j.str.2013.06.013S0969-2126(13)00214-1[pii]
Kenney B, Nassal F (1995) Evolutionary conservation in the hepatitis B virus core structure: comparison of human and duck cores. Structure 3:1009–1019
Klumpp K, Lam AM, Lukacs C, Vogel R, Ren S, Espiritu C, Baydo R, Atkins K, Abendroth J, Liao G, Efimov A, Hartman G, Flores OA (2015) High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein. Proc Natl Acad Sci USA 112(49):15196–15201. https://doi.org/10.1073/pnas.1513803112
Koschel M, Oed D, Gerelsaikhan T, Thomssen R, Bruss V (2000) Hepatitis B virus core gene mutations which block nucleocapsid envelopment. J Virol 74(1):1–7
Kratz PA, Bottcher B, Nassal M (1999) Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. Proc Natl Acad Sci USA 96(5):1915–1920
Lauber C, Seitz S, Mattei S, Suh A, Beck J, Herstein J, Borold J, Salzburger W, Kaderali L, Briggs JAG, Bartenschlager R (2017) Deciphering the origin and evolution of hepatitis B viruses by means of a family of non-enveloped fish viruses. Cell Host Microbe 22(3):387–399 e386. https://doi.org/10.1016/j.chom.2017.07.019
Lecoq L, Wang S, Wiegand T, Bressanelli S, Nassal M, Meier BH, Bockmann A (2018) Localizing conformational hinges by NMR: where do hepatitis B virus core proteins adapt for capsid assembly? ChemPhysChem 19(11):1336–1340. https://doi.org/10.1002/cphc.201800211
Le Pogam S, Chua PK, Newman M, Shih C (2005) Exposure of RNA templates and encapsidation of spliced viral RNA are influenced by the arginine-rich domain of human hepatitis B virus core antigen (HBcAg 165-173). J Virol 79(3):1871–1887. 79/3/1871 [pii] https://doi.org/10.1128/JVI.79.3.1871-1887.2005
Le Pogam S, Yuan TT, Sahu GK, Chatterjee S, Shih C (2000) Low-level secretion of human hepatitis B virus virions caused by two independent, naturally occurring mutations (P5T and L60V) in the capsid protein. J Virol 74(19):9099–9105
Liu C, Fan G, Wang Z, Chen HS, Yin CC (2017) Allosteric conformational changes of human HBV core protein transform its assembly. Sci Rep 7(1):1404. https://doi.org/10.1038/s41598-017-01568-9
Lutomski CA, Lyktey NA, Zhao Z, Pierson EE, Zlotnick A, Jarrold MF (2017) Hepatitis B virus capsid completion occurs through error correction. J Am Chem Soc 139(46):16932–16938. https://doi.org/10.1021/jacs.7b09932
Makbul C, Nassal M, Böttcher B (2020) Slowly folding surface extension in duck hepatitis B virus capsids governs its stability. eLife 9:e57277. https://doi.org/10.7554/eLife.57277
Milich DR, Peterson DL, Zheng J, Hughes JL, Wirtz R, Schodel F (1995) The hepatitis nucleocapsid as a vaccine carrier moiety. Ann N Y Acad Sci 754:187–201. https://doi.org/10.1111/j.1749-6632.1995.tb44451.x
Milich DR, Chen M, Schodel F, Peterson DL, Jones JE, Hughes JL (1997) Role of B cells in antigen presentation of the hepatitis B core. Proc Natl Acad Sci USA 94(26):14648–14653. https://doi.org/10.1073/pnas.94.26.14648
Muhamad A, Ho KL, Rahman MBA, Tejo BA, Uhrin D, Tan WS (2015) Hepatitis B virus peptide inhibitors: solution structures and interactions with the viral capsid. Org Biomol Chem 13(28):7780–7789. https://doi.org/10.1039/c5ob00449g
Nassal M (1992) Conserved cysteines of the hepatitis B virus core protein are not required for assembly of replication-competent core particles nor for their envelopment. Virology 190(1):499–505
Nassal M (2008) Hepatitis B viruses: reverse transcription a different way. Virus Res 134(1–2):235–249. https://doi.org/10.1016/j.virusres.2007.12.024
Nassal M, Leifer I, Wingert I, Dallmeier K, Prinz S, Vorreiter J (2007) A structural model for duck hepatitis B virus core protein derived by extensive mutagenesis. J Virol 81(23):13218–13229. JVI.00846-07 [pii] https://doi.org/10.1128/JVI.00846-07
Ning X, Luckenbaugh L, Liu K, Bruss V, Sureau C, Hu J (2018) Common and distinct capsid and surface protein requirements for secretion of complete and genome-free hepatitis B virions. J Virol 92(14). https://doi.org/10.1128/JVI.00272-18
Ning X, Nguyen D, Mentzer L, Adams C, Lee H, Ashley R, Hafenstein S, Hu J (2011) Secretion of genome-free hepatitis B virus–single strand blocking model for virion morphogenesis of para-retrovirus. PLoS Pathog 7(9):e1002255. https://doi.org/10.1371/journal.ppat.1002255
Ning X, Basagoudanavar SH, Liu K, Luckenbaugh L, Wei D, Wang C, Wei B, Zhao Y, Yan T, Delaney W, Hu J (2017) Capsid phosphorylation state and hepadnavirus virion secretion. J Virol 91(9). https://doi.org/10.1128/JVI.00092-17
O’Shea EK, Lumb KJ, Kim PS (1993) Peptide ‘Velcro’: design of a heterodimeric coiled coil. Curr Biol 3(10):658–667
Packianathan C, Katen SP, Dann CE, 3rd, Zlotnick A (2010) Conformational changes in the hepatitis B virus core protein are consistent with a role for allostery in virus assembly. J Virol 84(3):1607–1615. JVI.02033-09 [pii] https://doi.org/10.1128/JVI.02033-09
Pastor F, Herrscher C, Patient R, Eymieux S, Moreau A, Burlaud-Gaillard J, Seigneuret F, de Rocquigny H, Roingeard P, Hourioux C (2019) Direct interaction between the hepatitis B virus core and envelope proteins analyzed in a cellular context. Sci Rep 9(1):16178. https://doi.org/10.1038/s41598-019-52824-z
Ponsel D, Bruss V (2003) Mapping of amino acid side chains on the surface of hepatitis B virus capsids required for envelopment and virion formation. J Virol 77(1):416–422
Porterfield JZ, Dhason MS, Loeb DD, Nassal M, Stray SJ, Zlotnick A (2010) Full-length hepatitis B virus core protein packages viral and heterologous RNA with similarly high levels of cooperativity. J Virol 84(14):7174–7184. JVI.00586-10 [pii] https://doi.org/10.1128/JVI.00586-10
Qiu Z, Lin X, Zhou M, Liu Y, Zhu W, Chen W, Zhang W, Guo L, Liu H, Wu G, Huang M, Jiang M, Xu Z, Zhou Z, Qin N, Ren S, Qiu H, Zhong S, Zhang Y, Zhang Y, Wu X, Shi L, Shen F, Mao Y, Zhou X, Yang W, Wu JZ, Yang G, Mayweg AV, Shen HC, Tang G (2016) Design and synthesis of orally bioavailable 4-methyl heteroaryldihydropyrimidine based hepatitis B virus (HBV) capsid inhibitors. J Med Chem 59(16):7651–7666. https://doi.org/10.1021/acs.jmedchem.6b00879
Roseman AM, Berriman JA, Wynne SA, Butler PJ, Crowther RA (2005) A structural model for maturation of the hepatitis B virus core. Proc Natl Acad Sci USA 102(44):15821–15826
Salfeld J, Pfaff E, Noah M, Schaller H (1989) Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus. J Virol 63(2):798–808
Schaefer S (2007) Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13(1):14–21. https://doi.org/10.3748/wjg.v13.i1.14
Schlicksup CJ, Wang JC, Francis S, Venkatakrishnan B, Turner WW, VanNieuwenhze M, Zlotnick A (2018) Hepatitis B virus core protein allosteric modulators can distort and disrupt intact capsids. eLife 7. https://doi.org/10.7554/eLife.31473
Schodel F, Moriarty AM, Peterson DL, Zheng JA, Hughes JL, Will H, Leturcq DJ, McGee JS, Milich DR (1992) The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity. J Virol 66(1):106–114
Seitz S, Urban S, Antoni C, Bottcher B (2007) Cryo-electron microscopy of hepatitis B virions reveals variability in envelope capsid interactions. EMBO J 26(18):4160–4167. 7601841 [pii] https://doi.org/10.1038/sj.emboj.7601841
Selzer L, Katen SP, Zlotnick A (2014) The hepatitis B virus core protein intradimer interface modulates capsid assembly and stability. Biochemistry 53(34):5496–5504. https://doi.org/10.1021/bi500732b
Selzer L, Kant R, Wang JCY, Bothner B, Zlotnick A (2015) Hepatitis B virus core protein phosphorylation sites affect capsid stability and transient exposure of the C-terminal domain. J Bio Chem 290(47):28584-+. https://doi.org/10.1074/jbc.M115.678441
Skamel C, Ploss M, Böttcher B, Stehle T, Wallich R, Simon MM, Nassal M (2006) Hepatitis B virus capsid-like particles can display the complete, dimeric outer surface protein C and stimulate production of protective antibody responses against Borrelia burgdorferi infection. J Biol Chem 281(25):17474–17481
Stray SJ, Bourne CR, Punna S, Lewis WG, Finn MG, Zlotnick A (2005) A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly. Proc Natl Acad Sci USA 102(23):8138–8143
Summers J, Mason WS (1982) Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29(2):403–415. 0092-8674(82)90157-X [pii]
Ulrich R, Nassal M, Meisel H, Kruger DH (1998) Core particles of hepatitis B virus as carrier for foreign epitopes. Adv Virus Res 50:141–182. https://doi.org/10.1016/s0065-3527(08)60808-8
Venkatakrishnan B, Katen SP, Francis S, Chirapu S, Finn MG, Zlotnick A (2016) Hepatitis B virus capsids have diverse structural responses to small-molecule ligands bound to the heteroaryldihydropyrimidine pocket. J Virol 90(8):3994–4004. https://doi.org/10.1128/JVI.03058-15
Vogel M, Diez M, Eisfeld J, Nassal M (2005) In vitro assembly of mosaic hepatitis B virus capsid-like particles (CLPs): rescue into CLPs of assembly-deficient core protein fusions and FRET-suited CLPs. FEBS Lett 579(23):5211–5216. https://doi.org/10.1016/j.febslet.2005.08.044
Walker A, Skamel C, Nassal M (2011) SplitCore: an exceptionally versatile viral nanoparticle for native whole protein display regardless of 3D structure. Sci Rep 1:5. https://doi.org/10.1038/srep00005
Watts NR, Conway JF, Cheng N, Stahl SJ, Belnap DM, Steven AC, Wingfield PT (2002) The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface. EMBO J 21(5):876–884
Wingfield PT, Stahl SJ, Williams RW, Steven AC (1995) Hepatitis core antigen produced in Escherichia coli: subunit composition, conformational analysis, and in vitro capsid assembly. Biochemistry 34:4919–4932
Wu W, Chen Z, Cheng N, Watts NR, Stahl SJ, Farci P, Purcell RH, Wingfield PT, Steven AC (2013) Specificity of an anti-capsid antibody associated with Hepatitis B Virus-related acute liver failure. J Struct Biol 181(1):53–60. https://doi.org/10.1016/j.jsb.2012.10.004
Wynne SA, Crowther RA, Leslie AG (1999) The crystal structure of the human hepatitis B virus capsid. Mol Cell 3(6):771–780
Yuan TT, Sahu GK, Whitehead WE, Greenberg R, Shih C (1999) The mechanism of an immature secretion phenotype of a highly frequent naturally occurring missense mutation at codon 97 of human hepatitis B virus core antigen. J Virol 73(7):5731–5740
Yuan TT, Tai PC, Shih C (1999) Subtype-independent immature secretion and subtype-dependent replication deficiency of a highly frequent, naturally occurring mutation of human hepatitis B virus core antigen. J Virol 73(12):10122–10128
Yu X, Jin L, Jih J, Shih C, Zhou ZH (2013) 3.5A cryoEM Structure of hepatitis B virus core assembled from full-length core protein. PLoS One 8(9):e69729. https://doi.org/10.1371/journal.pone.0069729 PONE-D-13-04576 [pii]
Zhao Q, Hu Z, Cheng J, Wu S, Luo Y, Chang J, Hu J, Guo JT (2018) Hepatitis B virus core protein dephosphorylation occurs during pregenomic RNA encapsidation. J Virol 92(13). https://doi.org/10.1128/JVI.02139-17
Zhao Z, Wang JC, Gonzalez-Gutierrez G, Venkatakrishnan B, Asor R, Khaykelson D, Raviv U, Zlotnick A (2019) Structural differences between the woodchuck hepatitis virus core protein in the dimer and capsid states are consistent with entropic and conformational regulation of assembly. J Virol 93(14). https://doi.org/10.1128/JVI.00141-19
Zhou Z, Hu T, Zhou X, Wildum S, Garcia-Alcalde F, Xu Z, Wu D, Mao Y, Tian X, Zhou Y, Shen F, Zhang Z, Tang G, Najera I, Yang G, Shen HC, Young JA, Qin N (2017) Heteroaryldihydropyrimidine (HAP) and sulfamoylbenzamide (SBA) inhibit hepatitis B virus replication by different molecular mechanisms. Sci Rep 7:42374. https://doi.org/10.1038/srep42374
Zlotnick A, Venkatakrishnan B, Tan Z, Lewellyn E, Turner W, Francis S (2015) Core protein: a pleiotropic keystone in the HBV lifecycle. Antiviral Res 121:82–93. https://doi.org/10.1016/j.antiviral.2015.06.020
Zlotnick A, Cheng N, Conway JF, Booy FP, Steven AC, Stahl SJ, Wingfield PT (1996) Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein. Biochemistry 35(23):7412–7421
Acknowledgements
BB is supported by the German Research Foundation (DFG, BO1150/15-1).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Böttcher, B. (2021). Hepatitis B Core Protein Capsids. In: Harris, J.R., Marles-Wright, J. (eds) Macromolecular Protein Complexes III: Structure and Function. Subcellular Biochemistry, vol 96. Springer, Cham. https://doi.org/10.1007/978-3-030-58971-4_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-58971-4_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-58970-7
Online ISBN: 978-3-030-58971-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)